Post by
rockmoney on Nov 23, 2022 12:14pm
Opportunity?
This CML is one real sleeper. Looks like a good asset. Ugly balance sheet and all China management. Controlled by China entities. This needs a Canadian face and board to takeoff. But even at $0.10 looks cheap to me and has some upside. However, it's really limited by its current structure, China control and board.
Comment by
Whywhy3 on Jan 25, 2023 5:25am
A great opportunity make you Rich. The owner's average cost is at least $4 per share. I bet it will be rock up to $1.5/share if any good news come out... Of course, the owner won't lthe company die.... Hurry up....
Comment by
rockmoney on Feb 08, 2023 12:35pm
The owners average cost is irrelevent. Investors don't care what he or she paid for the shares. And if $4, that was stupid. I think they released their "good news" the PEA report and the stock is still dead at $0.08. I think they should sell this project to an operating company or a junior with the team to advance this.
Comment by
Whywhy3 on Jan 25, 2023 5:33am
100 mil debt is nothing for this company. Currently they have at least 50mil cash was invested in another bio company... Am I right?
Comment by
rockmoney on Feb 08, 2023 12:36pm
$100 million of debt is nothing? It's a disaster. That's why it trades at $0.08